Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Understanding when it’s too late to start retirement planning is crucial for your financial health. Take action to secure your future now.
19,461 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Bitcoin and gold ETFs have faced two weeks of net outflows, signaling a cooling of the debasement trade as investors ...
Gas prices are under pressure as refinery work continues and demand climbs. Analysts warn that prices likely remain h...
Geopolitical tensions with Iran have rattled energy markets, sending LNG-focused stocks lower while underscoring long...
As July 2026 begins, XRP hovers near $1.18 after a choppy June. Analysts say the price prediction July 2026 hinges on...
A rising capital markets wave is lifting expectations for banks, with a forecast of about 25% earnings growth for the...
US search interest in Bitcoin has surged to a five-year high even as prices remain in a bear market. Traders watch wh...
Sonic Automotive and Penske Automotive Group post mixed Q4 results as tariff fears shape growth paths. EchoPark expan...
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
A major hedge fund just placed a multi-million bet on a biotech company after FDA approval. This article breaks down ...
Snowflake posted a record quarter, but its stock trades far from its peak as investors weigh whether AI-driven growth...
Polymarket’s May Bitcoin question drew fierce scrutiny after a No resolution, later contradicted by a June filing sho...